Trial Profile
A treatment use protocol of entecavir in subjects with chronic hepatitis B infection who have failed or who are intolerant of available therapies
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 23 Sep 2016
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Expanded access; Therapeutic Use
- 14 Jul 2008 The expected completion date for this trial has been extended from Jun 2008 to 1 Aug 2008, as reported by Clinicaltrials.gov.
- 24 Oct 2005 New trial record.